Breakthrough Therapy Designation from the U.S. Food and Drug Administration Granted to Investigational HCV Regimen Containing Protease Inhibitor ABT-450 -- more

Enanta Announces New Data From Phase 2b Interferon-Free Combination Studies with Protease Inhibitor ABT-450 for Hepatitis C Treatment to be Presented at EASL -- more

Enanta Pharmaceuticals Announces IPO Pricing -- more

Dicerna Announces Patent Issuance for DsiRNAs Directed at the KRAS Gene, a Key Cancer Regulator -- more

Radius Health Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis Drug -- more

Diaxonhit/ExonHit: A Blood Test to Diagnose Alzheimer’s Disease? -- more

Xencor Receives Milestone Payment for Xtend™ Antibody -- more

Cambrios Demonstrates Accelerated Momentum with Multiple Announcements at the 2013 International CES -- more

Radius Provides Update on Pivotal Phase 3 Program for BA058-SC Injection -- more

Alan Walton: Westport scientist honored by Queen Elizabeth -- more

Dicerna Announces that Kyowa Hakko Kirin has Selected a Second DsiRNA Therapeutic Candidate for Development, Triggering $5 Million Milestone Payment -- more

Radius Completes Enrollment for Phase 2 Study of BA058-Transdermal Patch for Treatment of Postmenopausal Osteoporosis -- more

Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development -- more

Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin -- more

One of the leading US biotechnology venture funds enters into investor accreditation agreement with the Skolkovo Foundation -- more

Glori Energy Announces Collaboration with the Winogradsky Institute of Microbiology of the Russian Academy of Sciences -- more

Ceres Announces Closing of Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares -- more

Glori Energy enters contract with Petroleum Development Oman (PDO) -- more

Glori Energy Raises $20 Million -- more

Shell Strikes Coalbed Natural Gas Recovery R&D Deal With Luca Tech -- more

Glori Energy Signs Contract with Brazil's Petrobras -- more

From Bacteria to Barrels: Microbiology Having an Impact on Oil Fields -- more

Glori Energy jumps on IPO bandwagon -- more

Glori Energy: Oil-loving bugs enhance recovery in old and new reservoirs -- more